 |
[1] |
Jánossy
G, Marton A, Berczi I. The effect of long-term ethionine treatment
on the activity of serum properidin in rats. Z Immun Forsch 1965;129:115-119.
 |
| . |
[2] |
Molnár
K, Berczi I. Nachweis von parasitenspezifischen Antikörpen im Fishblut
mittels der Agar-Gel-Präzipitationsprobe (Demonstration of parasite-specific
antibodies in fish-blood by agar-gel-diffusion precipitation test). Z Immun
Frosch 1965;129:263-267.
|
|
[3] |
Berczi
I, Bertok L, Bereznay T. Comparative studies on the toxicity of
Escherichia
coli lipopolysaccaride endotoxin in various animal species. Can. J. Microbiol
1966;12:1070-71.
. |
|
[4] |
Berczi
I,Baintner K Jr, Antal T. Comparative assay of endotoxin by oral and parenteral
administration. Zbl Vet Med Reihe B 1966; 13:570-575.
|
|
[5] |
Berczi
I, Bertok L, Bereznay T. Osszehasonlitó toxicitási vizsgálatok
Escherichia coli lipopolysacharide endotixinjával különféle
állatfajokon (Comparative toxicological studies of E. coli lipopolysaccharide
endotoxin in various animal species). Kisérl Orvostud 1967;19:669-671. |
|
[6] |
Berczi
I. Endotoxin neutralizing effect of antisera to Escherichia coli
endotoxin.
Z Immun Forsch 1967;132:303-307.
|
|
[7] |
Berczi
I. Escherichia coli endotoxinnal elöállitott immunosavó
endotoxin közömbositö hatása (Neutralization of E.
coli endotoxin by antisera). Kisérl Orvostud 1967;19:282-284. |
|
[8] |
Berczi
I, Stipkovits L, Bereznay T, Antal T. The role of immunobiological
conditions
in E. coli - Disease of newborn calves. Zbl Vet Med Reihe B
1967;14:408-418.
|
|
[9] |
Berczi
I, Bereznay T, Bertok L, Stipkovits L. Neue beiträge zur pathophysiologie
der E.coli bedingten erkrankungen der saugkälber. Forspfl Haust (Jena)1967;3:400-405. |
|
[10] |
Berczi
I, Bertok L, Baintner K ,Jr, Veress B. Failure of oral Escherichia coli
endotoxin to induce either specific tolerance or toxic syndromes in rats.
J Path Bact 1968;96:481-486.
|
|
[11] |
Berczi
I. Stability of Escherichia coli endotoxin in the rat gastro-intestinal
tract.
J
Path Bact 1968;96:487-491.
|
|
[12] |
Nagy
Z, Berczi I, Bertok L. Experimental data on the pathogenesis of edema disease
of swine. Clinical picture, gross and microscopic lesions related to endotoxin
shock. Zbl Vet Med Reihe B 1968;15:504-511. |
|
[13] |
Berczi
I, Nagy A, Bertók L. Az escherichia coli endotoxin okozta
shock
klinikai,
kórbonctani és kórszövettani képe malacokban
(Clinical picture and
pathological
lesions of the shock in swine caused by E. coli endotoxin.).
Mag
Allatorv Lap.1968; 23:597-600. |
|
[14] |
Berczi
I, Bertók L, Baintner K, Veress B. Experiments to induce endotoxin
tolerance and toxic effect by perorally administered E. coli endotoxin
in rats.
Ann
Immun Hung 1968;12:117-121. |
|
[15] |
Berczi
I, Bereznay T, Bertók L. Stability of the toxic and serological
properties of E. coli endotoxin in the intestinal tract of rats. Ann Immun
Hung 1968;12:123-125. |
|
[16] |
Bertók
L., Berczi I. The effect of endotoxin tolerance on the lead acetate induced
endotoxin hypersensitivity of rats. Ann Immun Hung 1968;12:127-128. |
|
[17] |
Somogyi
A, Berczi I, Selye H. Inhibition by salicylates of various calcifying connective
tissue reactions. Arch Int Pharmacodyn 1969;177:211-223.
|
|
[18] |
Berczi
I, Somogyi A. Biochemical studies on the anticalcinotic effect of
salicylates.
Can J Physiol Pharmacol 1969;47:597-601.
|
|
[19] |
Berczi
I., Somogyi A., Selye H. Local inhibition of mastocalcergy by
calciphylactic
challengers. Eur J Pharmacol 1969;8:354-360.
|
|
[20] |
Selye
H, Berczi I. The present status of calciphylaxis and calcergy.
Clin
Orthop Related Res 1970; 69:23-43.
|
|
[21] |
Berczi
I. Fatty acids and soft tissue calcification. Exp Med Surg1970;18:245-255.
|
|
[22] |
Berczi
I., Sabbadini E., Sehon AH. In vivo destruction of tumor cells by
an
indirect
cell mediated immune mechanism. Immunol Commun 1972;1:1-9.
|
|
[23] |
Berczi
I. Studies in Tumor Immunology. Ph.D. Thesis, The University of Manitoba,
1972 |
|
[24] |
Berczi
I, Strausbauch P, Sehon AH. Rejection of Tumor cells in vitro.
Science
1973;180:1289-1291.
|
|
[25] |
Linford
JH, Froese G, Berczi I, Israels L.G. (1974) An alkylating agent-globulin
conjugate
with both alkylating and antibody activity. J Nat Cancer Inst 1974;52:1665-1667.
|
|
[26] |
Froese
G, Berczi I, Sehon AH. Neuraminidase-induced enhancement of tumor
growth
in mice. J Nat Cancer Inst 1974;52:1905-1908.
|
|
[27] |
Huang
JCC, Berczi I, Froese G, Tsay HM, Sehon AH.
A
microradioimmunoassay for antibodies to tumor-associated antigens.
J
Nat Cancer Inst 1975;55:879-886.
|
|
[28] |
Berczi
I, Sehon AH. Rejection of tumor cells in vitro: A T-cell mediated
reaction.
Int J Cancer 1975;16:665-674.
|
|
[29] |
Conrad
D.H., Berczi I., Froese A. Characterization of the target cell receptor
for IgE. I. Receptor complexes from rat mast cells and rat basophilic leukemia
cells.
Immunochem
1976;13:329-332.
|
|
[30] |
Berczi
I, Tsay HM , Sehon AH. Efferent enhancement of a
methylcholanthrene-induced
sarcoma transplantable in strain 13 guinea pigs.
Eur
J Immunol 1976; 6:453-455.
. |
|
[31] |
Berczi
I, Lee WY, Sehon AH. A rapid radioimmunoassay for determination of
tumor antigens with reference to carcinoembryonic antigen. Protides of
Biological Fluids, Peeters H, editor. 1976; 24:617-620. |
|
[32] |
Abe
S, Berczi I Sehon AH. Susceptibility to and escape from complement-
mediated
lysis of guinea pig hepatoma line-10. Int J Cancer 1977;20:137-145.
|
|
[33] |
Abe
S, Berczi I, Sehon AH. Resistance of guinea-pig hepatoma cells to
complement-mediated
lysis induced by ascites fluid or serum from tumor-bearing animals. Int
J Cancer 1977;20:595-606.
|
|
[34] |
Berczi
I, Sehon AH. Tumor inhibition by effector cells cultured from progressing
sarcomas.
Immunol Commun 1977;6:617-632.
|
|
[35] |
Shalev
A, Berczi I, Hamerton JL. Demonstration of fluorescent X and Y
bodies
after antibody-and complement-mediated cytotoxicity. Immunogenetics
1977;5:405-414. |
|
[36] |
Shalev
A, Berczi I, Hamerton JL. Detection and cross-reaction of H -Y
antigen
by haemagglutination. Immunogenetics 1978;5:303-312.
|
|
[37] |
Nagy
E, Berczi I. Immunodeficiency in hypophysectomized rats.
Acta
Endocrinol 1978; 89:530-537.
|
|
[38] |
Lee
FH, Berczi I, Fujimoto S, Sehon AH. The use of anti-fibrin antibodies for
the destruction of tumor cells. III. Complete regression of MC-D sarcomas
in guinea pigs by conjugates of Daunomycin and anti-fibrin antibodies.
Cancer Immunol Immunother 1978;5:201-206. |
|
[39] |
Shalev
A, Berczi I, Hamerton JL. The H-Y antigen: Production of antibodies, detection,
and cross-reaction between mouse, rat, and human. Cytogenet Cell Genet
1978;22:672-675.
|
|
[40] |
Berczi
I., Sehon A.H. Effector and suppressor lymphoid cells in tumor bearing
guinea
pigs. Int J Cancer 1979;23:274-282.
|
|
[41] |
.Berczi
I, McMorris LS, Thorlakson TK, Thorlakson RH, Kellen JA, Sehon AH.
Detection of tumor antibodies in patients with gastrointestinal carcinomas
by
a
solid phase radioimmunoassay. J Nat Cancer Inst 1979; 63:553-566.
|
|
[42] |
Berczi
I, Kovács K, Horváth E, Sehon AH. Rejection of tumor cells
in
vitro:
Morphological
studies on killer T cells and damaged tumor cells. Int. Arch. Allergy Appl.Immunol.
1979;59:1-12.
|
|
[43] |
Wang
KC, Berczi I, Sehon AH. Effector and enhancing lymphoid cells in
plasmacytoma
bearing mice. I. Methodological studies on the Winn assay.
Int.
J. Cancer 1980;25:487-492.
|
|
[44] |
Wang
KC, Berczi I, Hoffman EG, Sehon AH. Effector and enhancing lymphoid
cells
in plasmacytoma bearing mice II. Dynamic changes during tumor progression.
Int J Cancer 1980;25:493-501.
|
|
[45] |
Berczi
I, Froese G. Antigen(s) expressed on cultured cells of various species
that
cross-react with tumor antigen(s). Tissue Antigen 1980;16:260-264.
. |
|
[46] |
McComb
DJ, Ilse G, Ryan N, Horvath E, Kovacs K, Nagy E, Berczi I.
Histologic,
immunocytologic and subcellular changes in the rat adenohypophysis caused
by prolactin, growth hormone and ACTH-producing transplanted pituitary
tumors:
A comparison with spontaneous prolactin-producing adenomas. Exp Pathol
1980;18:213-222.
|
|
[47] |
Tsukuda
K., Berczi I., Klein G. Human B lymphocytes activated by Epstein-Barr
virus
(EBV) or by mitogens suppress mitogen-induced immunoglobulin production.
J Immunol 1981;126:1810-1813.
|
|
[48] |
McComb
DJ, Ryan N, Horvath E, Kovacs K, Nagy E, Berczi I, Domokos I,
Laszlo
FA. Five different adenomas from the rat adenohypophysis: An
immunocytochemical
and ultrastructural study. J Nat Cancer Inst 1981; 66:1103-1111.
|
|
[49] |
Nagy
E, Berczi I. Prolactin and contact sensitivity. Allergy 1981;36:429-431.
|
|
[50] |
Berczi
I, Nagy E, Kovacs K, Horvath E. Regulation of humoral immunity in
rats
by pituitary hormones. Acta Endocrinol 1981;98:506-513.
. |
|
[51] |
Berczi
I, Nagy E. A possible role of prolactin in adjuvant arthritis. Arthritis
Rheum
1982;25:591-594.
|
|
[52] |
Froese
G, Berczi I, Israels LG. Tumor cell-antibody interactions. I.
In
vivo
experiments.
Immunology 1982;45:303-312.
|
|
[53] |
Froese
G., Berczi I., Israels L.G. (1982) Tumor cell antibody interactions.
II. In vitro studies. Immunology 1982;45:313-323.
|
|
[54] |
Nagy
E, Berczi I, Freisen HG. Regulation of immunity in rats by lactogenic
and
growth hormones. Acta Endocrinol 1983;102:351-357.
|
|
[55] |
Berczi
I, Nagy E, Asa SL, Kovacs K. Pituitary hormones and contact
sensitivity
in rats. Allergy 1983;38:325-330.
|
|
[56] |
Berczi
I. Cancer Immunology - Quo Vadis? An overview. J Exp Clin Cancer
Res 1983;2:135-144. |
|
[57] |
Berczi
I, Holford-Strevens V, Warsi ZH, McMorris LS, Thorlakson RH, Thorlakson
TK,Sehon AH. Tumor-reactive IgE antibodies in plasma of patients
with
gastrointestinal
carcinomas. Cancer Immunol Immunother 1983;14:180-184.
|
|
[58] |
Nagy
E, Berczi I, Wren GE, Asa SL, Kovacs K. Immunomodulation by
bromocriptine.
Immunopharmacology 1983;6:231-243.
. |
|
[59] |
Berczi
I, Nagy E, Asa SL, Kovacs K. The influence of pituitary hormones
on
adjuvant
arthritis. Arthritis Rheum 1984;27:682-688.
|
|
[60] |
Nagy
E, Friesen HG, Sehon AH, Berczi I. Immunomodulation in rats by
transplantable
anterior pituitary tumors. Endocrinology 1985;116:1117-1122.
|
|
[61] |
Berczi
I. Pituitary
Function and Immunity. Berczi I,editor ,Monograph published by: Boca
Raton, FL:CRC Press Inc., 1986. |
|
[62] |
Berczi
I. Preface. In: Berczi I, editor. Pituitary
Function and Immunity. Monograph published by:Boca Raton, FL: CRC Press,
Inc., 1986; i-ii. |
|
[63] |
Berczi
I. The immune system and its function. In: Berczi I, editor. Pituitary
Function and Immunity. Monograph published by: Boca Raton, FL:CRC
Press, Inc., 1986;1-25. |
|
[64] |
Berczi
I. Pituitary malfunction and immune abnormalities. In: Berczi I, editor.
Pituitary
Function and Immunity.Monograph published by: Boca Raton, FL:CRC Press,
Inc., 1986;41-47. |
|
[65] |
Berczi
I. The influence of pituitary-adrenal axis on the immune system. In: Berczi
I, editor. Pituitary
Function and Immunity. Monograph published by:Boca Raton, FL: CRC Press,
Inc.,1986;49-131 |
|
[66] |
Berczi
I. The effects of growth hormone and related hormones on the immune system.
In: Berczi I, editor. Pituitary
Function and Immunity. Monograph published by:Boca Raton, FL: CRC Press,
Inc., 1986;133-159. |
|
[67] |
Berczi
I, Nagy E. Prolactin and other lactogenic hormones. In: Berczi I, editor.
Pituitary
Function and Immunity. Monograph published by:Boca Raton, FL:CRC Press,
Inc., 1986;161-183. |
|
[68] |
Berczi
I. Gonadotropins and sex hormones. In: Berczi I, editor. Pituitary
Function and Immunity.Monograph published by:Boca Raton, FL: CRC Press,
Inc., 1986;185-211. |
|
[69] |
Berczi
I. The pituitary thyroid axis. In: Berczi I editor, Pituitary
Function and Immunity. Monograph published by: Boca Raton, FL:CRC Press,
Inc., 1986;213-219. |
|
[70] |
Berczi
I. The effect of miscellaneous hormones and neurotransmitters on the immune
system. In: Berczi I, editor. Pituitary
Function and Immunity. Monograph published by: Boca Raton, FL:CRC Press,
Inc., 1986;221-225. |
|
[71] |
Beczi
I. Immunoregulation by the pituitary gland. In: Berczi I, editor. Pituitary
Function and Immunity. Monograph published by: Boca Raton, FL:CRC
Press, Inc., 1986;227-240. |
|
[72] |
Berczi
I. The influence of hormones on infectious and parasitic disease. In: Berczi
I, editor. Pituitary
Function and Immunity. Monograph published by:Boca Raton, FL: CRC Press,
Inc., 1986;273-283. |
|
[73] |
Nagy
E, Berczi I. Immunomodulation by tamoxifen and pergolide. Immunopharmacology
1986;12:145-153
|
|
[74] |
Chan
BMC, McNeill K, Berczi I, Froese A. Effect of mycoplasma infection on Fc
receptors for IgE of rat basophilic leukemic cells. Eur J Immunol 1986;16:1319-1324 |
|
[75] |
MacDonald
G, Primrose S, Biggins K, Bowman JM, Berczi I, Friesen AD,
Sehon
AH. Production and characterization of human-human and human-mouse hybridomas
secreting Rh(D) specific monoclonal antibodies. Scan J Immunol 1987;25:477-483.
|
|
[76] |
Berczi
I, Kovacs K, editors. Hormones and Immunity. Lancaster, U.K., MTP
Press Ltd., 1987. |
|
[77] |
Berczi
I, Nagy E. The effect of prolactin and growth hormone on hemolymphopoietic
tissue and immune function. In: Berczi I, Kovacs K, editors,
Hormones and Immunity. Lancaster, UK, MTP Press Ltd., 1987;145-171. |
|
[78] |
McKenzie
CE, Berczi I. Estrogen dependent suppression of mitogen response in rat
lymphocytes. Acta Endocrinol 1987;116:200-204.
|
|
[79] |
Berczi
I, Cosby H, Hunter T, Baragar F. McNeilly AS, Friesen HG. Decreased bioactivity
of circulating prolactin in patients with rheumatoid arthritis. Brit J
Rheum 1987;26:433-436.
|
|
[80] |
Berczi
I. The influence of pituitary hormones and neurotransmitters on the immune
system. EOS Riv Immun Immunofarm 1988;8:186-194. |
|
[81] |
Ramachandra
RN, Berczi I, Sehon AH. Human-human hybridomas secreting lipid-A reactive
monoclonal antibodies. Immunol Lett 1988;18:93-98.
|
|
[82] |
Berczi
I. Immunoregulation by neuroendocrine factors. Develop Comp Immunol 1989;13:329-341.
|
|
[83] |
Nagy
E, Berczi I. Pituitary dependence of bone marrow function. Brit J Haematol
1989;71:457-462.
|
|
[84] |
Baral
E, Kwok S, Berczi I. Suppression of lymphocyte mitogenesis by tamoxifen.
Immunopharmacology 1989;18:57-62.
|
|
[85] |
Berczi
I. Neurohormonal immunoregulation. Endocrine Pathol 1990;1:197-219. |
|
[86] |
Berczi
I. Neurohormonal-immune interactions. In: Kovacs K, Asa S, editors. Functional
Endocrine Pathology,Vol. 2. Blackwell Scientific Publications
Inc. 1991;990-1004. |
|
[87] |
Berczi
I, Nagy E. Effects of hypophysectomy on immune function. In: Ader R, Felten
DL, Cohen N, editors. Psychoneuroimmunology
II, Academic Press 1991;339-375. |
|
[88] |
Berczi
I, Nagy E, Matusik RJ, Friesen HG. Pituitary hormones regulate c-myc and
DNA synthesis in lymphoid tissue. J Immunol 1991;146:2201-2206.
|
|
[89] |
Nagy
E, Berczi I. Hypophysectomized rats depend on residual prolactin for survival.
Endocrinology 1991;128:2776-2784.
|
|
[90] |
Baral
E, Kwok S, Berczi I. The influence of estradiol and tamoxifen on the mixed
lymphocyte reaction in rats. Immunopharmacology 1991;21:191-198.
|
|
[91] |
Ramachandra
RN, Berczi I, Rector ES, Sehon AH. Development and characterization of
ouabain resistant human fusion partners. J Immunol Method 1991;142:21-29.
|
|
[92] |
Nagy
E, Chalmers IM, Baragar FD, Friesen HG, Berczi I. Prolactin deficiency
in rheumatoid arthritis. J Rheumatol 1991;18:1662-1668.
|
|
[93] |
Nagy
E, Berczi I, Sehon AH. Inhibition of the H2712 MTV positive mammary carcinoma
in C3H/HeJ mice by murine monoclonal IgE anti-MTV antibodies. Cancer Immunol
Immunother 1991;34:63-69.
|
|
[94] |
Berczi
I, Nagy E. Placental lactogen is a hemopoietic hormone. Brit J Haematol
1991;79:355-358.
|
|
[95] |
Zheng
Y, Chan BMC, Rector ES, Berczi I, Froese A. Establishment and characterization
of hybrid rat mast cells. Exp Cell Res 1991;194:301-309.
|
|
[96] |
Ramachandra
RN, Sehon AH, Berczi I. Neuro-hormonal host defence in endotoxin shock.
Brain Behav Immun 1992;6:157-169.
|
|
[97] |
Berczi
I. The immunology of prolactin. Seminars in Reproductive Endocrinology,
special issue on "Prolactin in Women," McCoshen JA, editor. 1992;10:196-219. |
|
[98] |
Nagy
E, Berczi I, Sabbadini S. Endocrine control of the immunosuppressive activity
of the submandibular gland. Brain Behav Immun 1992:418-428.
|
|
[99] |
Ramachandra
RN, Berczi I, Sehon AH, Berczi I. Inhibition of lipid A and lipopolysaccharide
(LPS) induced cytokine secretion, B cell mitogenesis and lethal shock by
lipid A specific murine monoclonal antibodies. J Infect Dis 1993;167:1151-1159.
|
|
[100] |
Berczi
I. Editorial: Prolactin, pregnancy and autoimmune disease. J Rheumatol
1993;20:1095-1100.
|
